Literature DB >> 846297

Hypertriglyceridemia in Ehrlich ascites carcinomatous mice: tumor and mouse strain differences.

R Kannan, N Baker.   

Abstract

Ehrlich ascites carcinoma growth in mice induces hypertriglyceridemia. The degree of hypertriglyceridemia found in one laboratory (Spector's) was much greater than we observed in our laboratory. Moreover, major differences were reported with respect to fasting (no effect on tumor extracellular fluid triglyceride levels in Spector's tumor-bearing mice; marked decrease in ours). We have obtained tumorous CBA mice from Spector's laboratory and have studied them simultaneously with our Swiss-Webster mice. Triglyceride levels of the above two groups and from two controlled crossover groups, included to evaluate the influence of mouse and tumor strains on hypertriglyceridemia, were determined. The CBA mice had intense hypertriglyceridemia and high triglyceride levels in tumor extracellular fluid regardless of the subline source of ascites tumor. On the other hand, only mild hyperlipidemia was induced with both strains of tumor in Swiss-Webster mice. Thus, the variations in plasma and tumor extracellular fluid triglyceride levels probably arise from the mouse strains and not from variations in the tumor subline. Fasting caused a decrease in both plasma and tumor extracellular fluid triglyceride concentrations in CBA, as well as in Swiss-Webster mice. A mouse strain difference was also evident from a significant decrease in wet weights of adipose tissues like epididymal fat, inguinal fat, and intermuscular fat with tumor growth in the CBA strain which was not observed in the Swiss-Webster strain at the corresponding stage of tumor growth. Study of these strain diffeences may lead to an understanding of factors that regulate hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 846297     DOI: 10.1007/BF02533286

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  10 in total

1.  UPTAKE OF FREE FATTY ACIDS BY EHRLICH ASCITES TUMOR CELLS.

Authors:  A A SPECTOR; D STEINBERG; A TANAKA
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  Adaptation of orbital bleeding technic to rapid serial blood studies.

Authors:  V RILEY
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

3.  Abnormal fat absorption in tumor-bearing rats.

Authors:  I POSNER
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

4.  Characterization of the hyperlipidemia in mice bearing the Ehrlich ascites tumor.

Authors:  D E Brenneman; S N Mathur; A A Spector
Journal:  Eur J Cancer       Date:  1975-04       Impact factor: 9.162

5.  Contribution of intermuscular fat to lipogenesis from dietary glucose carbon in mice.

Authors:  R Kannan; D L Palmquist; N Baker
Journal:  Biochim Biophys Acta       Date:  1976-05-27

6.  Glycerolphosphate oxidoreductases and the glycerophosphate cycle in ehrlich ascites tumor cells.

Authors:  K Letnansky; G M Klc
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

7.  Influence of body weight, age, diet and sex on fat depots in rats.

Authors:  R Schemmel; O Mickelsen; U Mostosky
Journal:  Anat Rec       Date:  1970-03

8.  The importance of free fatty acid in tumor nutrition.

Authors:  A A Spector
Journal:  Cancer Res       Date:  1967-09       Impact factor: 12.701

9.  Tumor extracellular triglycerides in mice during growth of Ehrlich ascites carcinoma.

Authors:  R Kannan; N Baker
Journal:  Lipids       Date:  1975-12       Impact factor: 1.880

10.  Flux of free fatty acids among host tissues, ascites fluid, and Ehrlich ascites carcinoma cells.

Authors:  P Mermier; N Baker
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

  10 in total
  6 in total

1.  Lipid composition of Morris hepatoma 5123c, and of livers and blood plasma from host and normal rats.

Authors:  S Ruggieri; A Fallani
Journal:  Lipids       Date:  1979-09       Impact factor: 1.880

2.  Changes in host animal plasma lipids during hepatoma growth.

Authors:  M Matocha; R Wood
Journal:  Lipids       Date:  1980-06       Impact factor: 1.880

3.  Lipid composition of Yoshida ascites hepatoma and of livers and blood plasma from host and normal rats.

Authors:  S Ruggieri; A Fallani
Journal:  Lipids       Date:  1979-04       Impact factor: 1.880

4.  The role of dietary fat and hepatic triglyceride secretion in cancer-induced hypertriglyceridemia.

Authors:  R Kannan; L Wilson; N Baker
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

5.  Essential and nonessential fatty acid oxidation in mice bearing Ehrlich ascites carcinoma.

Authors:  M Ookhtens; N Baker
Journal:  Lipids       Date:  1982-02       Impact factor: 1.880

6.  Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).

Authors:  S Dessì; B Batetta; O Spano; G J Bagby; L Tessitore; P Costelli; F M Baccino; P Pani; J M Argilès
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.